Aims & Scope
In recent years, a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases, whereby most of our diseases are related to intra- and intercellular communication disorders. The concept of signal transduction therapy has become the forefront of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth/mini-reviews, research articles, and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling, e.g., cancer and neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all researchers involved in drug design and discovery.
Abstracted & Indexed in:
Archiving and Copyright:
Journal Database:
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
Related Journals
Related Books
Mind Maps in Clinical Biochemistry
A Treatise on Ecological Science
From SARS-CoV to MARS-CoV
Microbiology for ICAR NET: A Comprehensive Exam Preparation Guide
Decolorization by Thanatephorus Cucumeris Dec 1
Industrial Applications of Soil Microbes
The Future of Agriculture: IoT, AI and Blockchain Technology for Sustainable Farming
Handbook of Integrated Weed Management for Major Field Crops
Practical Biochemistry
Anticancer Drugs Sourced from Marine Life
